In order to study the putative monoamine oxidase (MAO) inhibitory side effect of neuroleptics and simultaneous changes in platelet serotonin content both MAO-B activity and serotonin (5-HT) content in platelets of 30 healthy volunteers and 50 schizophrenic patients treated with neuroleptics were investigated. Our results have shown significantly lower MAO-B activity (15.26 ± 6.81 S.D. vs. 8.63 ± 3.82mmol/hour/109 platelets) and higher platelet 5-HT content (906.19 ± 285.33 vs. 1,727.85 ± 947.40ng/109 platelets) in the schizophrenic group. Platelet MAO-B activity was considerably lower in paranoid and residual schizophrenics compared with other patients, however, no difference was found in platelet 5-HT content between different subtypes of schizophrenia. Various neuroleptic treatments did not produce different effects either on platelet serotonin content or platelet MAO-B activity.
CITATION STYLE
Mészáros, Z., Borcsiczky, D., Máté, M., Tarcali, J., Tekes, K., & Magyar, K. (1998). MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients. Journal of Neural Transmission, Supplement, (52), 79–85. https://doi.org/10.1007/978-3-7091-6499-0_9
Mendeley helps you to discover research relevant for your work.